Notification of name change for Enoxaparin BECAT® (enoxaparin sodium)
ROVI Biotech would like to announce that Enoxaparin BECAT® (enoxaparin sodium) has changed its name to AROVI®.
The name change is due to a mandatory request made by the Medicines and Healthcare Products Regulatory Agency (MHRA). ROVI Biotech Ltd has been requested to change Enoxaparin BECAT® brand name to a new one where the name “enoxaparin” is not included in the denomination. ROVI has been informed that “Enoxaparin BECAT®”, the brand name initially approved and launched in the UK does not comply with the biosimilar naming regulations.
The new name approved by the MHRA is AROVI®.
Both products are identical (including the safety device), there are no changes to the medicine that will remain with the same product licence numbers (PL numbers).
The only difference is in the packaging, that will feature the AROVI® name and the ordering codes (EAN and PIP codes) that are different.
We hope this will not cause too much inconvenience and would like to reassure you that we are doing everything we can to make this transition as seamless as possible.
If you have any queries or concerns or should you require further information, please do not hesitate to contact us on 02 03 642 06 77 or [email protected]